Applicants having applied for authorisation as cannabis intermediate product manufacturers

Updated 19 October 2020
Theme image medicinal cannabis with tex

The companies below have applied to be authorised as cannabis intermediate product manufacturers (as at 19 October 2020):


Applicants whose applications are pending a decision:

  • Tetra Pharm Technologies ApS 
  • Medican A/S


Applicants who have been grated authorisations:

  • Scanleaf ApS
  • Movianto Nordic ApS (authorisation valid from 23 September 2020)
  • Sterigenics Denmark A/S (authorisation valid from 18 December 2019)
  • Schroll Medical ApS (authorisation valid from 16 October 2019)
  • Aurora Nordic Cannabis A/S (authorisation valid from 18 January 2019)
  • Spectrum Cannabis Denmark ApS (previously Spectrum Cannabis Denmark ApS. Authorisation for producing cannabis intermediate products from cannabis grown in Denmark valid from 6 May 2019)
  • STENOCARE A/S (authorisation valid from 1 March 2018)
  • CannGros Aps (authorisation valid from 1 January 2018)


Applicants whose applications have been refused or have expired:

  • Medcan Pharma A/S (authorisation denied)


Applicants whose applications have been withdrawn or closed:

  • Solural Pharma ApS (authorisation withdrawn)
  • Bornholmerhampen IVS (authorisation closed)
  • Mads Pallisgaard Petersen (authorisation closed)
  • Agrima Botanicals ApS (authorisation closed)
  • HB Medical Hørsholm ApS (authorisation closed)
  • Medican Pharma ApS (authorisation withdrawn)
  • Nomeco ApS (authorisation closed)
  • Københavns Universitet, Institut for Plante- og Miljøvidenskab (authorisation closed)
  • Relief ApS (authorisation closed)
  • Medical Cannabis Import (authorisation closed)


Unless otherwise stated, the review of applications is still ongoing, and more applications may be added.


Read more about application and manufacture of cannabis intermediate products

Did you get answers to your questions?

Please tell us how we can improve our website? Please note that we do not answer questions asked via this feature.